| Literature DB >> 26842066 |
Bo Jin1, Yifan Zhao1, Shiying Hao2, Andrew Young Shin3, Yue Wang2, Chunqing Zhu1, Zhongkai Hu1, Changlin Fu1, Jun Ji1, Yong Wang4,5, Yingzhen Zhao2, Yunliang Jiang2, Dorothy Dai1, Devore S Culver6, Shaun T Alfreds6, Todd Rogow6, Frank Stearns1, Karl G Sylvester2, Eric Widen1, Xuefeng B Ling7.
Abstract
BACKGROUND: Estimating patient risk of future emergency department (ED) revisits can guide the allocation of resources, e.g. local primary care and/or specialty, to better manage ED high utilization patient populations and thereby improve patient life qualities.Entities:
Mesh:
Year: 2016 PMID: 26842066 PMCID: PMC4739399 DOI: 10.1186/s12873-016-0074-5
Source DB: PubMed Journal: BMC Emerg Med ISSN: 1471-227X
Fig. 1Study design to develop the ED revisit predictive algorithm. A flow chart of 5 steps from cohort construction to prospective validation is demonstrated. Maine healthcare information was extracted to build a retrospective and prospective cohorts. Samples in the retrospective cohort were randomly split into 3 sub-cohorts (Cohort I, II and III) for training, calibrating and blind testing of a decision_tree_based predictive model. Two thresholds of 0.3 and 0.7 were applied to the ranked outputs of the model to divide the population into low, medium and high risk groups. The model together with the risk stratification was validated on the prospective cohort by PPV, sensitivities and ROC
Fig. 2Retrospective cohort construction. The final cohort includes 293,461 ED encounters between Jan 1, 2012 and Dec 31, 2012. 120 encounters associated with patients who have died were excluded from the database. It consisted of 4 subgroups based on the past-year ED visit and chronic disease histories, and was randomly split into 3 parts for training, calibrating and blind testing purposes
Fig. 3Prospective cohort construction. The final cohort includes 193,886 ED encounters between Jan 1, 2013 and Jun 30, 2013. 105 encounters associated with patients who have died were excluded from the database
ED 6 month revisit risk stratification results
| Characteristics | Retrospective | Prospective | ||||
|---|---|---|---|---|---|---|
| (Jan. 1, 2012 – Dec. 31, 2012) | (Jan. 1, 2013 – Jun. 30, 2013) | |||||
| Risk score threshold | Risk score threshold | |||||
| 50 | 70 | 80 | 50 | 70 | 80 | |
| No. of ED encounters | 95,785 | 75,593 | 49,109 | 62,189 | 47,235 | 28,166 |
| Positive predictive value | 0.614 | 0.696 | 0.83 | 0.597 | 0.669 | 0.794 |
| Sensitivity | 0.758 | 0.598 | 0.389 | 0.716 | 0.544 | 0.324 |
| Specificity | 0.639 | 0.802 | 0.94 | 0.608 | 0.781 | 0.931 |
| Average ED visits in the future 6 months | 2.13 | 2.74 | 4.11 | 2.32 | 3.01 | 4.77 |
Fig. 4The ED predictive algorithm effectively risk-stratified the prospective patient cohort for future 6-month ED visit. Left panel: Unsupervised clustering of the high-risk patients identified distinct subgroups in the prospective cohort. Color-coding reflects the ED resource utilization of the high-risk patients in the next 6-month post discharge. Right panel: Prospective ED revisit rates and counts for each cluster at 1, 3 and 6 months’ points
Clustering of prospective ED-6-month high-risk patients according to demographics and the prior year clinical histories
| Characteristics | Cluster | ||||||
|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | ||
| Number of encounters | 41,887 | 10,218 | 6361 | 4798 | 4231 | 3101 | |
| Resource utilization | Average total lab test | 124.75 | 230.98 | 278.51 | 514.73 | 175.55 | 351.06 |
| Average total Radiology | 7.39 | 19.41 | 20.05 | 60 | 17.83 | 38.77 | |
| Average future 6 month ED counts | 2.68 | 2.56 | 4.53 | 4.06 | 4.58 | 2.15 | |
| Demographics | Sex (Female) | 55.87 | 52.63 | 72.96 | 57.29 | 72.89 | 47.53 |
| Age new born | 1.59 | 0.02 | 0.44 | 0 | 0.05 | 0 | |
| Age 1–5 | 4.66 | 0.22 | 0.85 | 0 | 0.38 | 0 | |
| Age 6–12 | 2.97 | 0.39 | 1.01 | 0 | 1.21 | 0 | |
| Age 13–18 | 4.25 | 0.82 | 2.56 | 0.02 | 2.65 | 0 | |
| Age 19–34 | 39.39 | 9.89 | 35.97 | 5.79 | 47.67 | 0.35 | |
| Age 35–49 | 21.75 | 19.5 | 30.26 | 18.92 | 32.95 | 5.61 | |
| Age 50–65 | 13.73 | 28.49 | 19.64 | 35.16 | 11.65 | 16.48 | |
| Age >65 | 11.65 | 40.67 | 9.28 | 40.1 | 3.45 | 77.56 | |
| Chronic disease conditions | Total Chronic disease conditions | 1.87 | 6.35 | 6.42 | 15.26 | 4.34 | 12.2 |
| Percentage of encounters without chronic diseases | 24.8 | 0 | 0 | 0 | 0 | 0 | |
| Other hematologic conditions | 0.07 | 0.15 | 0.09 | 0.13 | 0.05 | 0.06 | |
| Cancer of pancreas | 0.03 | 0.14 | 0.02 | 0.25 | 0.07 | 0.23 | |
| Pulmonary heart disease | 0.07 | 0.03 | 0.09 | 0.06 | 0.05 | 0.03 | |
| Transient cerebral ischemia | 0.06 | 0.06 | 0.06 | 0 | 0.02 | 0 | |
| Diabetes mellitus with complications | 0.05 | 0.02 | 0.03 | 0 | 0 | 0.06 | |
| Systemic lupus erythematous & connective tissue disorders | 0.05 | 0.04 | 0.02 | 0 | 0.02 | 0 | |
| Disorders of lipid metabolism | 0.04 | 0.05 | 0 | 0 | 0.02 | 0.06 | |
| Anxiety disorders | 0.03 | 0.06 | 0.02 | 0.06 | 0 | 0 | |
| Genitourinary symptoms and ill defined conditions | 0.02 | 0.03 | 0.02 | 0.04 | 0 | 0.03 | |
| Epilepsy convulsions | 0.01 | 0.01 | 0.02 | 0.08 | 0 | 0.06 | |
| Hyperplasia of prostate | 0.03 | 0 | 0.02 | 0 | 0 | 0 | |
| Immunity disorders | 0.03 | 0 | 0.02 | 0 | 0 | 0 | |
| Other complications of pregnancy | 0.01 | 0.01 | 0.02 | 0.06 | 0.02 | 0.03 | |
| Other diseases of bladder and urethra | 0.01 | 0.01 | 0.02 | 0.06 | 0.02 | 0.03 | |
| Cancer of kidney and renal pelvis | 0.02 | 0.01 | 0.03 | 0.02 | 0.02 | 0 | |
| Open wounds of extremities | 0.02 | 0 | 0.02 | 0 | 0.02 | 0 | |
| Other non epithelial cancer of skin | 0 | 0.01 | 0.05 | 0 | 0.02 | 0.06 | |
| Other nutritional endocrine and metabolic disorders | 0 | 0.01 | 0.05 | 0 | 0.02 | 0.06 | |
| Cancer other and unspecified primary | 0.02 | 0 | 0 | 0 | 0.02 | 0 | |
| Biliary tract disease | 0.01 | 0.02 | 0 | 0 | 0 | 0.03 | |
Characteristics of resource utilization, demographics and chronic disease conditions were summarized for each cluster. All the data shown within the headers of demographics and chronic disease conditions were expressed in percentages (%)
Fig. 5Geographic distribution of the prospective ED 6-month revisits and ED facilities in Maine State. Top panel: revisits of all ED encounters. Bottom panel: revisits of high risk ED encounters. The heatmap color metric indicates the average revisit rates in percentage (which equals to the number of ED encounters which returned within future 6 months divided by the total number of the ED encounters) at each location identified by zip codes. The maps were generated using Microsoft Power Map for Excel